台灣臨床試驗主持人資料庫|TPIDB

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberMK-3475-669/ ECHO-304

Completed

2017-11-20 - 2022-11-21

Phase III

Terminated5

ICD-10C44.42

Squamous cell carcinoma of skin of scalp and neck

ICD-9195.0

Malignant neoplasm of other and ill-defined sites of head, face and neck

Trial Applicant

Merck Sharp & Dohme (I.A.) LLC
Sponsor
Trial scale

Multi-Regional Multi-Center
Update

2026/06/01

Investigators and Locations

Principal Investigator RUEY-LONG HONG Division of Hematology & Oncology

National Taiwan University Hospital

Co-Principal Investigator

廖斌志 Division of Hematology & Oncology
Hsiang-Fong Kao Division of Hematology & Oncology
YA-FANG CHEN Division of Radiology

The Actual Total Number of Participants Enrolled

0 Terminated

Audit

None

Principal Investigator Tai-Jan Chiu Division of Hematology & Oncology

Kaoshiung Chang Gung Memorial Hospital of the C.G.M.F.

Co-Principal Investigator

林偉哲 Division of Radiology
黃泰霖 Division of Hematology & Oncology
陳彥豪 Division of Hematology & Oncology
Shau-Hsuan Li Division of Hematology & Oncology
劉建廷 Division of Hematology & Oncology
Yu-Li Su Division of Hematology & Oncology
林偉雄 Division of Radiology

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 林進清 Division of Radiation Therapy

Taichung Veterans General Hospital

Co-Principal Investigator

林敬薇 Division of Radiation Therapy
YI-CHUN LIU Division of Radiation Therapy
陳建志 Division of Radiation Therapy
李權 Division of Radiation Therapy

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Su-Peng Yeh Division of Hematology & Oncology

China Medical University Hospital

Co-Principal Investigator

Ching Yun Hsieh Division of Hematology & Oncology
Wei-Ching Lin Division of Radiology
Chi-Ching Chen Division of Hematology & Oncology
Ming-Hung Tsai Division of Hematology & Oncology
Ming-Yu Lien Division of Hematology & Oncology

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator

China Medical University Hospital-Taipei

Co-Principal Investigator

Su-Peng Yeh 未分科

Audit

None

Principal Investigator Chia-Jui Yen Division of Hematology & Oncology

National Taiwan University Hospital

Co-Principal Investigator

Shang-Yin Wu Division of Hematology & Oncology
劉奕廷 Division of Hematology & Oncology
Kwang-Yu Chang Division of Hematology & Oncology

Audit

None

Principal Investigator Hung-Ming Wang Division of Hematology & Oncology

Linkou Chang Gung Medical Foundation

Co-Principal Investigator

Chi-Ting Liau Division of Hematology & Oncology
廖俊達 Division of Hematology & Oncology
Tung-Chieh Chang Division of Radiation Therapy
Tzu-Chen Yen Division of Nuclear Medicine
Chia-Hsun Hsieh Division of Hematology & Oncology
Shu-Hang Ag Division of Radiology
Cheng-Lung Hsu Division of Hematology & Oncology
Li-Yu Lee Division of Others -

Clinical Trials List

Investigators and Locations

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants